For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250808:nRSH6500Ua&default-theme=true
RNS Number : 6500U Benchmark Holdings PLC 08 August 2025
FOR IMMEDIATE RELEASE
8 August 2025
Benchmark Holdings plc
("Benchmark" or the "Company")
Update on Euronext Oslo Børs approval of the cancellation of the trading of
Benchmark's shares from Euronext Growth Oslo and the cancellation of trading
of the Company's shares on AIM
Further to the approval by shareholders of the resolution in respect of the
cancellation of the admission to trading of the Company's shares from Euronext
Growth Oslo and AIM at the general meeting of Benchmark held on 18 June 2025
and satisfaction of other conditions (including the closing of the Tender
Offer), Benchmark requested Euronext Oslo Børs to delist its shares from
trading and official listing on Euronext Growth Oslo on 19 June 2025.
Euronext Oslo Børs has today approved the application to delist Benchmark's
shares from Euronext Growth Oslo.
Following the approval from Euronext Oslo Børs, the timeline for the
Cancellations is now expected to be as follows:
· 8 August 2025: Approval of the delisting application by Euronext
Oslo Børs.
· 15 August 2025: Last day of trading of the shares on Euronext
Growth Oslo and on AIM.
· 18 August 2025: The cancellations of the admission to trading of
the Company's shares on AIM and on Euronext Growth Oslo becomes effective at
7.00 a.m. UK time in respect of AIM and 8.00 a.m. CET in respect of Euronext
Growth Oslo.
Enquiries:
Benchmark Holdings plc benchmark@mhpgroup.com
Trond Williksen, CEO
Ivonne Cantu, Investor Relations
Strand Hanson Limited (Nominated & Financial Adviser and Broker)
Christopher Raggett/James Dance/Rob Patrick Tel: +44 (0) 20 7409 3494
MHP
Katie Hunt/Reg Hoare/Samuel Garner Tel: +44 (0) 7890 952 661
benchmark@mhpgroup.com
The person responsible for arranging the release of this announcement on
behalf of the Company is Ivonne Cantu, Investor Relations.
ABOUT BENCHMARK
Benchmark is a market leading aquaculture biotechnology company. Benchmark's
mission is to drive sustainability in aquaculture by delivering products and
solutions in advanced nutrition and health which improve yield, growth and
animal health and welfare. Find out more at www.benchmarkplc.com
OTHER NOTICES
This announcement is not intended to and does not constitute an offer to buy
or the solicitation of an offer to subscribe for or sell or an invitation to
purchase or subscribe for any securities or the solicitation of any vote in
any jurisdiction. The release, publication or distribution of this
announcement in whole or in part, directly or indirectly, in, into or from
certain jurisdictions may be restricted by law and therefore persons in such
jurisdictions should inform themselves about and observe such restrictions.
Strand Hanson Limited ("Strand Hanson") is authorised and regulated by the
Financial Conduct Authority in the UK and is acting as financial and nominated
adviser and broker to the Company and no one else in connection with the
matters described in this announcement and will not be responsible to anyone
other than the Company for providing the protections afforded to clients of
Strand Hanson nor for providing advice in connection with the matters referred
to herein. Neither Strand Hanson nor any of its affiliates (nor any of their
respective directors, officers, employees or agents), owes or accepts any
duty, liability or responsibility whatsoever (whether direct or indirect,
whether in contract, tort, under statute or otherwise) to any person who is
not a client of Strand Hanson in connection with the matters set out in this
announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END UPDBDGDISGGDGUI